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The Human Microbiome Project
(HMP) [1,2] is a concept that was long
in the making. After the Human Ge-
nome Project, interest grew in sequenc-
ing the ‘‘other genome’’ of microbes
carried in and on the human body
[3,4]. Microbial ecologists, realizing that
.99% of environmental microbes could
not be easily cultured, developed ap-
proaches to study microorganisms in situ
[5], primarily by sequencing the 16S
ribosomal RNA gene (16S) as a phylo-
genetic and taxonomic marker to identify
members of microbial communities [6].
The need to develop corresponding new
methods for culture-independent studies
[7,8] in turn precipitated a sea change in
the study of microbes and human health,
inspiring the new term ‘‘metagenomics’’
[9] both to describe a technological
approach—sequencing and analysis of
the genes from whole communities rath-
er than from individual genomes—and
to emphasize that microbes function
within communities rather than as indi-
vidual species. This shift from a focus on
individual organisms to microbial inter-
actions [10] culminated in a National
Academy of Science report [11], which
outlined challenges and promises for
metagenomics as a way of understanding
the foundational role of microbial com-
munities both in the environment and in
human health.
Pioneering medical microbiologists
applied these approaches, finding far
more microbial diversity than expected
even in well-studied body site habitats
[12]. Technological advances further
enabled sequencing of communities
across the human body, and immunolo-
gists began exploring the fundamental
role of microorganisms in the maturation
of the innate and adaptive immune
systems. Initial metagenomic studies of
human-associated microbial communi-
ties were performed using the traditional
Sanger platform [13,14]. Upon intro-
duction of pyrosequencing [15], the
number of 16S-based data sets increased
dramatically [16,17]. The time was right
to invest in a concerted study of the
microbial communities associated with
the human body and the metabolic
capabilities they provide—the human
microbiome (Figure 1) [18].
To coordinate these efforts relating the
microbiome to human health, the NIH
Common Fund launched the HMP as a
community resource program (http://
commonfund.nih.gov/hmp/) [19]. One
of its main goals was to create a baseline
view of the healthy human microbiome
in five major areas (airways, skin, oral
cavity, gastrointestinal tract, and vagina)
and to make this resource available to
the broad scientific community. Charac-
terizing the baseline state of the micro-
biota is a critical first step in determining
how altered microbial states contribute
to disease (e.g., [13,20–23]). Previous
work showed wide inter- and intra-
personal diversity of human-associated
microbes [24], necessitating analysis of a
large number of subjects and character-
ization of many reference bacterial
genomes [25] to assist in interpretation
of metagenomic data. The scope of the
HMP thus required a particularly diverse
consortium (Figure 2A), and collabora-
tion among these teams ultimately stim-
ulated research growth throughout the
field and produced a study including the
first consistent sampling of many clini-
cally relevant body habitats, within a
large population, with paired 16S profil-
ing and deep metagenomic sequencing
coverage for hundreds of microbial
communities.
The HMP required careful consider-
ation of ethical, legal, and social impli-
cations (ELSI) unique to the study of the
microbiome [26]. Such research raises
questions regarding traditional distinc-
tions between self and non-self, human
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and non-human, genetics and environ-
ment, and health and disease. The
prospect of manipulating the microbiota
in ways that could permanently alter an
individual’s biological identity requires
the development of new ethical para-
digms analogous to, but not identical to,
those already considered for gene thera-
py. Likewise, just as gene patents have
proven controversial, defining who
‘‘owns’’ a microbiome raises difficult
questions of intellectual property. The
ELSI team helped to develop an appro-
priate sample collection protocol, to draft
a template for informed consent, and
consulted on ethical issues arising during
the study, such as the possibility that
unique human microbiome ‘‘signatures’’
[27] might compromise participant pri-
vacy. A portion of the HMP’s dedicated
research budget continues to be commit-
ted to integrating multidisciplinary ap-
proaches (including philosophical, social
science, and legal methods) to study these
issues and involve stakeholders including
study participants, scientists, policy mak-
ers, patients, and indigenous populations.
Planning for Human
Microbiome Studies: Tools,
Techniques, and Design
Any study of human populations must
put both subject protection and study
design first, and the HMP was no excep-
tion. Power calculations for microbiome
studies in human cohorts are particularly
challenging, as they must simultaneously
address assay types (e.g., 16S versus shot-
gun), depth of sequencing, taxon detection,
and fold abundance changes in clades,
genes, or pathways of interest [28–31].
After study design, as the HMP spanned
multiple sequencing centers over a pro-
longed duration, the group established
standardized and benchmarked protocols
for sample collection [2], handling, and
subsequent 16S profiling [32]. Metage-
nomic library construction was likewise
standardized among centers, and stringent
quality control was aided by the optimiza-
tion of 16S read processing [33] and by
improved taxonomic frameworks for clas-
sification of microbial sequences prior to
biological interpretation [34].
Finally, quality data generation from
appropriately designed microbiome stud-
ies enables a variety of subsequent com-
putational analyses (Figure 2B). While we
refer the reader to existing broader reviews
of human microbiome bioinformatics [35–
37], here we highlight numerous recent
approaches specifically developed during
the HMP. Several of these focused on
microbial interactions, such as ecological
network reconstruction [38,39]. Other
computational methods dealt with meta-
genomic sequences, including both assem-
bly-based [40,41] and assembly-free anal-
yses of microbial community membership
[42] and metabolic function [43]. Both
data types enable taxonomic and phylo-
genetic profiling [44,45], and ecological
metrics proved to associate microbial,
gene, and pathway diversity on an un-
precedented scale [2]. The HMP Data
Analysis Coordination Center (DACC,
http://hmpdacc.org) hosts all available
HMP data and many tools, focusing the
tremendous quantity of raw data through
lenses such as SitePainter [46]; IMG/
HMP, an HMP-specific version of the
Figure 1. Timeline of microbial community studies using high-throughput sequencing. Each circle represents a high-throughput
sequence-based 16S or shotgun metagenomic bioproject in NCBI (May 2012), indicating the amount of sequence data produced for each project
(circle area and y-coordinate) at the time of publication/registration (x-coordinate). Projects are grouped by human-associated (red), other animal
(black), or environmental (green) communities, and shotgun metagenomic projects are marked with a grey band. Selected representative projects are
labeled: open ocean [68], deep sea [69], lean mouse [70], diarrheal illness [71], costal ocean [72], lean/obese gut [53], human microbiome [56],
MetaHIT (gut) [58], cow rumen [73], soil (NCBI BioProject PRJNA50473), and human gut [74]. Note that HMP has deposited a total of 7.44 terabases of
shotgun data in SRA, of which 49% is host DNA derived data that was filtered and only available through protected access in dbGaP project
phs000228.
doi:10.1371/journal.pbio.1001377.g001
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Integrated Microbial Genomes (IMG [47])
system; METAREP [48]; and MG-RAST
[49], and efforts are ongoing to provide
these data for meta-analysis alongside
other human microbiome studies in the
cloud.
Community Structure, Function,
and a ‘‘Core’’ Human
Microbiome
The HMP was designed in part to
address a key question about our microbial
selves: do all humans have an identifiable
‘‘core’’ microbiome of shared components
comparable to our shared genome [50]?
Several definitions of ‘‘core’’ have been
proposed, recently unified in one concep-
tual framework [51]. Earlier studies re-
ported that different people shared few
microbes in their gut and skin microbiota
[17,52–56], a greater fraction of their oral
microbiota [56,57], or might be classifi-
able into multiple core microbiomes based
on vaginal [20] and gut communities [58].
The HMP provides a comprehensive
picture of the human microbiome cover-
ing multiple body sites and thus an in-
depth exploration of these concepts. The
study confirmed high inter-individual var-
iation [59] and showed that even rare
organisms in these communities are im-
portant reservoirs of genetic diversity [60].
Additionally, the large HMP cohort shows
that the composition of the gut micro-
biome rarely clusters subjects into discrete
types, as was suggested before on more
limited data [61]; although other habitats
such as the vagina can exhibit such
clustering [20], the gut was most often
characterized by smooth abundance gra-
dients of key organisms [2].
A potentially more universal ‘‘core’’
human microbiome emerged during the
consideration of microbial genes and
pathways carried throughout communi-
ties’ metagenomes. While microbial or-
ganisms varied among subjects as de-
scribed above, metabolic pathways
necessary for human-associated microbial
life were consistently present, forming a
functional ‘‘core’’ to the microbiome at all
body sites [2,43,53]. Although the path-
ways and processes of this core were
consistent, the particular genes that im-
plemented them again varied. Microbial
sugar utilization, for example, was en-
riched for metabolism of simple sugars in
the oral cavity, complex carbohydrates in
the gut, and glycogen/peptidoglycan deg-
radation in the vaginal microbiome [62].
The healthy microbiome may thus achieve
a consistent balance of function and
metabolism that is maintained in health,
but with fine-grained details personalized
by genetics, early life events, environmen-
tal factors such as diet, and a lifetime of
pharmaceutical and immunological expo-
sures [41].
The Healthy Microbiome
Informs Studies of Disease
Data from individuals without overt
signs of disease serve as an excellent
reference for disease-associated micro-
biome studies, while also providing a
comprehensive baseline for comparison
of Western populations with disparate
geographic, ethnic, and genetic cohorts
[63]. The adoption of uniform sampling,
nucleic acid extraction, sequencing, and
analysis protocols is an important step in
such integration, with some success al-
ready realized in, for example, several
aspects of autoimmune disease. The in-
flammatory bowel diseases have long been
linked to the human gut microbiome [22],
with integration of host genotype, gene
expression, and microbial membership
now suggesting mediation of specific
host-microbial interactions by human gene
products as well as by host environment
[64,65]. Bacteria are of course not the only
mediators of dysbiotic disease, and meta-
genomic approaches can also be used to
identify potential viral etiologies (e.g., in
pediatric fever of undefined origin [66]).
Likewise the ‘‘healthy’’ microbiome pro-
Figure 2. HMP consortium activities as a model for microbiome data generation and analyses. (A) Initiatives within the HMP coordinated
to isolate samples, generate data, perform analysis, and publish results. Technology development was employed to develop novel bacterial culture and
DNA isolation techniques. Ethical Legal and Social Implications (ELSI) work anticipated societal implications and guided policies associated with human
subject microbiomes. Clinical sites were collected samples from large cohorts of healthy individuals, with nucleotide sequence information derived at
four sequencing centers at the Baylor College of Medicine (BCM), the Broad Institute, the J. Craig Venter Institute (JCVI), and the Washington University
Genome Institute (WUGI). Additional demonstration projects assessed primarily microbiome alterations related to disease. In addition to analysis
throughout the HMP consortium, computational tools were funded to address, for example, genome assembly, microbial ecology, and statistical
modeling. A data analysis and coordination center provided a portal to all data generated. (B) Overview of the analysis approaches that were the
ultimate product of the HMP consortium, corresponding to data products and protocols available at http://hmpdacc.org.
doi:10.1371/journal.pbio.1001377.g002
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vides a baseline not only for integration
with disease-related studies, but for broad-
er populations such as a recent compari-
son using HMP protocols among a cohort
of pregnant women [67]. The normal
variation of the microbiome within
healthy states and its potential misregula-
tion in disease is thus being pursued in
earnest, as related laboratory and compu-
tational methods continue to be adapted
to better characterize the impact of
bacteria, archaea, viruses, and fungi
throughout human body habitats.
The HMP has thus greatly advanced
our knowledge of the microbes in a
healthy adult reference population, and
provided much-needed infrastructure in
terms of reference genomes, laboratory
protocols, computational methods, and
ELSI considerations [1,2] to help enable
a vast range of studies that will likely find
associations between human-associated
microbial communities and disease. The
next steps will be to discover which of
these microbial community changes result
from disease and which cause it, to
understand how healthy variation relates
to variation within the context of different
disorders, and to use a combination of
laboratory and computational techniques
to begin unraveling causal mechanisms on
levels ranging from the molecular to the
societal. In particular, the study of indi-
viduals of all ages and across cultures,
together with prospective longitudinal
studies and careful work in in vitro and
animal models, will be critical to develop-
ing both the science and the technology
that will allow us to alter our microbial
genomes, far easier to alter than the host
genome within each of our ‘‘human’’ cells,
in order to maintain and improve health.
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